CareDx, Inc (CDNA)
NASDAQ: CDNA · IEX Real-Time Price · USD
9.19
+0.01 (0.11%)
May 2, 2024, 10:14 AM EDT - Market open
CareDx Revenue
In the year 2023, CareDx had annual revenue of $280.32M, a decrease of -12.89%. Revenue in the quarter ending December 31, 2023 was $65.57M, a -20.41% decrease year-over-year.
Revenue (ttm)
$280.32M
Revenue Growth
-12.89%
P/S Ratio
1.70
Revenue / Employee
$441,455
Employees
635
Market Cap
475.84M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 280.32M | -41.47M | -12.89% |
Dec 31, 2022 | 321.79M | 25.40M | 8.57% |
Dec 31, 2021 | 296.40M | 104.20M | 54.22% |
Dec 31, 2020 | 192.19M | 65.13M | 51.25% |
Dec 31, 2019 | 127.07M | 50.50M | 65.95% |
Dec 31, 2018 | 76.57M | 28.25M | 58.45% |
Dec 31, 2017 | 48.32M | 7.69M | 18.93% |
Dec 31, 2016 | 40.63M | 12.49M | 44.37% |
Dec 31, 2015 | 28.14M | 838.00K | 3.07% |
Dec 31, 2014 | 27.31M | 5.21M | 23.57% |
Dec 31, 2013 | 22.10M | 1.65M | 8.05% |
Dec 31, 2012 | 20.45M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Community Health Systems | 12.52B |
Orthofix Medical | 746.64M |
LifeMD | 152.55M |
Surmodics | 138.20M |
Avid Bioservices | 136.74M |
Arbutus Biopharma | 18.14M |
Verve Therapeutics | 11.76M |
Oculis Holding AG | 1.05M |
CDNA News
- 2 days ago - CareDx to Report First Quarter 2024 Financial Results - Business Wire
- 12 days ago - CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 15 days ago - CareDx Appoints John W. Hanna as its New President and Chief Executive Officer - Business Wire
- 23 days ago - CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting - Business Wire
- 7 weeks ago - CareDx Appoints Bryan Riggsbee to Its Board of Directors - Business Wire
- 2 months ago - CareDx Announces Fourth Quarter and Full Year 2023 Financial Results - Business Wire
- 2 months ago - CareDx to Participate in the Raymond James & Associates' 45th Annual Institutional Investors Conference - Business Wire
- 2 months ago - CareDx to Report Fourth Quarter and Full Year 2023 Financial Results - Business Wire